Results 121 to 130 of about 112,331,922 (208)
Schematic overview of the multi‐target and multi‐pathway mechanisms of PDBI in the prevention and management of hypertension. ABSTRACT Hypertension remains a major global risk factor for cardiovascular diseases, yet current treatments face challenges such as suboptimal blood pressure control and inadequate organ protection.
Qiqi Deng +6 more
wiley +1 more source
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
We report missense mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) in seven large pedigrees affected with Charcot-Marie-Tooth neuropathy type 2A (CMT2A).
Yuji Takahashi +151 more
core +1 more source
Pyroptotic macrophages release extracellular vesicles enriched in miR‐103a‐3p. These EVs are taken up by granulosa cells, where miR‐103a‐3p targets MFN2 and BCL2L13, disrupting mitochondrial homeostasis and increasing oxidative stress and apoptosis. This EV‐mediated signaling axis contributes to diminished ovarian reserve and represents a potential ...
Wenhan Ju +5 more
wiley +1 more source
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley +1 more source
Using skin fibroblasts from people with Huntington's disease, we compared selective inhibition of the two forms of the protein kinase GSK‐3. Inhibiting either GSK‐3α or GSK‐3β reduced a signaling pathway involved in cell growth and metabolism.
Yarine Lugassy +4 more
wiley +1 more source
Our previous study demonstrated that elevated levels of desmin and vimentin reduce BSM contractility. This study shows that the reduced BSM contractility is associated with mitochondrial impairment. G0/G1 switch gene 2 (G0S2) is upregulated in desmin‐ and vimentin‐overexpressing BSM.
Elham Javed +21 more
wiley +1 more source
Zebrafish mitofusin-2 knockdown: a new model for CMT2A neuropathy?
Mitofusin 2 (MFN2) is a large dynamin-like GTPase protein, located in the outer membrane of mitochondria and at the surface of the endoplasmic reticulum.
VETTORI, ANDREA +7 more
core
The Role of Mammalian Mitofusin-2 (Mfn-2) in Lipid Metabolism [PDF]
The architecture of mitochondria is closely associated with numerous functions for cell signaling, growth and senescence. The overall phenomenon of mitochondrial dynamics, which include fusion and fission events, characterizes the fundamental mechanism ...
Ambilwade, Prashant of 1984-
core
Lidamycin induces mitophagy in pancreatic cancer cells by regulating the expression of Mfn2
Lidamycin (LDM) has been confirmed to have a strong anti-pancreatic cancer effect and can affect the mitochondrial function of pancreatic cancer cells. Mitofusin-2 (Mfn2) is located in the outer membrane of mitochondria, and Mfn2 is currently believed to
Boya Wu +3 more
doaj +1 more source
Mitofusin 2 (MFN2) mutations cause mitochondrial DNA instability in Charcot-Marie-Tooth disease
Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of inherited peripheral neuropathies and it affects at least 1 in 2,500 individuals. A specific autosomal-dominant axonal CMT subtype, hereditary motor and sensory neuropathy type VI (HMSN-VI ...
Patrick Yu-Wai-Man; Kamil Sitarz; Joanna Stewart; Angela Pyle; Mary Reilly; Rita Horvath; Patrick Chinnery
core

